← Back to Search
Management Of Sarcoma In The Asia-Pacific Region: Resource-stratified Guidelines.
J. Lewin, A. Puri, R. Quek, R. Ngan, A. P. Alcasabas, D. Wood, D. Thomas
Published 2013 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Sarcomas are a rare and diverse set of cancers that disproportionately affect young people. The best possible outcome depends on access to highly specialised, multidisciplinary care. Although advances have been made in therapeutic techniques, access to some treatments might be limited by cost implications. This Review proposes an evidence-based, consensus recommendation for optimum management of bone and soft-tissue sarcoma across the Asia-Pacific region, taking into account variation in health-care resources, stratified according to the Breast Health Global Initiative resource levels. A web-based survey of 89 clinicians involved in the care of patients with sarcoma from 18 Asia-Pacific countries generated the recommendations for diagnosis, staging, and management, including supportive and palliative care, and research.
This paper references
Scintigraphically negative skip metastasis in osteosarcoma
S. Bhagia (1997)
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy
C. Franzius (2000)
Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Matthias Schwarzbach (2000)
High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Metastatic Rhabdomyosarcoma—A Systematic Review
F. Peinemann (2011)
Molecular Diagnosis of Ewing Sarcoma Family of Tumors: A Comparative Analysis of 560 Cases With FISH and RT-PCR
I. Machado (2009)
Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
S. Tangjitgamol (2009)
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
E. Borden (1987)
A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
N. Pervaiz (2008)
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.
S. Grobmyer (2004)
Ewing's sarcoma family of tumors: current management.
M. Bernstein (2006)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
W. Graaf (2012)
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
R. Womer (2012)
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.
J. Wee (2009)
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
S. Patel (1997)
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
N. Penel (2008)
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma.
A. Davis (2005)
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
George D. Demetri (2009)
MRI and CT evaluation of primary bone and soft-tissue tumors.
A. Aisen (1986)
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
J. Anninga (2011)
Methotrexate for high‐grade osteosarcoma in children and young adults
E. C. V. Dalen (2011)
Molecular mechanisms underlying human synovial sarcoma development.
N. R. Santos (2001)
Health and health-care systems in southeast Asia: diversity and transitions
V. Chongsuvivatwong (2011)
Predictive pathology: a pathologist's perspective
P. Waring (2003)
Utilization of positron emission tomography in the management of patients with sarcoma
M. Benz (2009)
Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up.
M. Paulussen (2009)
Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
E. Fellinger (1991)
Pathology and genetics of tumours of soft tissue and bone
C. D. Fletcher (2002)
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years.
G. Bacci (2000)
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
P. W. Pisters (1996)
Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.
G. Ku (2012)
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
P. J. Woll (2012)
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
C. Franzius (2001)
Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
S. Bielack (2009)
The international incidence of childhood cancer
D. Parkin (1988)
Chemotherapy compliance in patients with osteosarcoma
J. Bajpai (2013)
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
Y. Kwong (2009)
Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
L. Hong (2004)
SIOP‐PODC recommendations for graduated‐intensity treatment of retinoblastoma in developing countries
G. Chantada (2013)
Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease.
B. Demas (1988)
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
V. Bramwell (1992)
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
L. Kager (2003)
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
E. Bastiaannet (2004)
Supportive, palliative, and end-of-life care for patients with cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.
S. Payne (2012)
Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry.
R. Ladenstein (1995)
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
P. Meyers (2001)
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome.
G. Zagars (2003)
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
S. Ferrari (2005)
Guideline implementation for breast healthcare in low‐ and middle‐income countries
C. Yip (2008)
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
K. Antman (1989)
Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.
C. Ripamonti (2009)
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P. Hogendoorn (2012)
Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
A. Italiano (2009)
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
B. O'Sullivan (2002)
High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma.
R. Admiraal (2010)
The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): Pooled analysis of the two STBSG-EORTC phase III clinical trials
A. Cesne (2008)
Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma
B. Yong (2012)
Biopsy of Soft Tissue Masses: Evidence-based Medicine for the Musculoskeletal Tumor Society
B. Rougraff (2009)
Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas.
M. Christie-Large (2008)
UK Guidelines for the Management of Bone Sarcomas
R. Grimer (2010)
Guidelines for the Management of Soft Tissue Sarcomas
R. Grimer (2010)
Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
G. McArthur (2005)
Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies
S. Malempati (2012)
ACR Appropriateness Criteria® screening for pulmonary metastases.
T. Mohammed (2011)
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.
D. Poon (2009)
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
R. Soo (2009)
National survival trends of young adults with sarcoma
A. Bleyer (2005)
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
A. V. van Oosterom (2002)
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma.
V. H. Bramwell (2003)
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
V. Bramwell (1994)
Analysis of prognostic factors in ewing sarcoma family of tumors
C. Rodriguez-Galindo (2007)
The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts.
O. Delattre (1994)
Pelvic Ewing sarcoma
C. Hoffmann (1999)
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.
A. Davis (2002)
The Multidisciplinary Management of Osteosarcoma
N. Federman (2009)
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
M. Paulussen (2008)
Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation.
P. Picci (2001)
Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
O. Oberlin (2006)
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
J. Yang (1998)
India's patent case victory rattles Big Pharma
P. Chatterjee (2013)
Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010.
Pattara Wiromrat (2012)
International patterns of cancer incidence in adolescents.
C. Stiller (2007)
International variations in the incidence of childhood soft-tissue sarcomas.
C. Stiller (1994)
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
H. Grier (2003)
Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas.
T. Delaney (2005)
ACCURACY OF COMPUTED TOMOGRAPHY GUIDED CORE NEEDLE BIOPSY OF MUSCULOSKELETAL TUMOURS
Altay O. Altuntas (2005)
Growth, employment and inequality in Brazil, China, India and South Africa: An overview
E. Arnal (2010)
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992.
G. Bacci (2004)
Soft tissue sarcomas.
J. Cormier (2004)
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee
J. Meyer (2008)
Liposarcoma: Molecular Genetics and Therapeutics
R. Conyers (2011)
The role of core needle biopsy in the diagnosis of suspected soft tissue tumours
D. Strauss (2010)
Guideline implementation for breast healthcare in low‐income and middle‐income countries
B. Anderson (2008)
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009.
N. S. Wong (2009)
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
M. Hensley (2002)
Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas.
R. Palumbo (1997)
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
L. Mirabello (2009)
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
E. Gortzak (2001)
PREOPERATIVE CORE BIOPSY OF SOFT TISSUE TUMOURS FACILITATES THEIR SURGICAL MANAGEMENT: A 10‐YEAR UPDATE
Dixon T S Woon (2008)
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
M. Nesbit (1990)
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
T. La (2006)
Soft tissue sarcoma.
G. Demetri (2010)
Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma.
F. Barr (1998)
Fine Needle Aspiration Biopsy of Primary Bone Tumors
W. Ward (2000)
Analysis of prognostic factors in 333 Chinese patients with high‐grade osteosarcoma treated by multidisciplinary combined therapy
D. Min (2013)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
G. Demetri (2002)
Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group.
S. Mostert (2011)
Adolescent and young adult oncology: an emerging field.
D. Thomas (2010)
Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.
S. Williams (2013)
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.
A. Italiano (2009)
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects.
K. Janeway (2010)
Docetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysis
J. Bay (2006)
This paper is referenced by
Orthopedic Oncology – “The Challenges Ahead”
A. Puri (2014)
Wiki-Based Clinical Practice Guidelines for the Management of Adult Onset Sarcoma: A New Paradigm in Sarcoma Evidence
S. J. Neuhaus (2015)
Soft tissue sarcoma in Asia.
E. Poon (2018)
Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
T. Kubo (2016)
Management of lower extremity soft-tissue sarcoma in a sub-Saharan African teaching hospital: Case reports
O. Ayandipo (2019)
Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.
C. Rodríguez-Galindo (2015)
Multidisciplinary Approach to Treatment: An Australian Perspective
S. J. Neuhaus (2017)
A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma
J. Lewin (2014)
Rare chondrosarcoma of the breast treated with quadrantectomy instead of mastectomy: A case report
V. Pasta (2015)
Noriyuki Koyama (2016)
Survival-associated alternative splicing signatures in soft tissue sarcomas.
Xianghai Ren (2020)
Sustainable care for children with cancer: a Lancet Oncology Commission.
R. Atun (2020)
The medico-legal observation of an aggressive urogenital fibromatosis with isolated development not related to any traumatic event.
E. Muccino (2016)
Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors.
Wen'E Cai (2017)
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
Guoshuang Shen (2018)
Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians
J. Lewin (2017)
Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt
A. M. Morsy (2019)
Battle Against Musculoskeletal Tumors: Descriptive Data of Military Hospital Experience
Cagri Neyisci (2020)
Giant cell tumor of the small bones of the foot
H. L. Co. (2018)
Estudio descriptivo de las características epidemiológicas, patológicas y de tratamiento en pacientes tratados por Sarcoma en el Instituto Oncológico Nacional de Panamá desde 2004 al 2011.
Yair Ruiz (2014)
Orthopedic oncology - "the challenges ahead"
Vasileios S Nikolaou (2014)
Caraterização Histopatológica e Imuno-histoquímica de Sarcomas e Carcinossarcomas Mamários Caninos
Antonio Ramos (2016)
Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging
Esha Baidya Kayal (2020)